AP2333A - Product and method. - Google Patents

Product and method.

Info

Publication number
AP2333A
AP2333A AP2005003317A AP2005003317A AP2333A AP 2333 A AP2333 A AP 2333A AP 2005003317 A AP2005003317 A AP 2005003317A AP 2005003317 A AP2005003317 A AP 2005003317A AP 2333 A AP2333 A AP 2333A
Authority
AP
ARIPO
Prior art keywords
product
Prior art date
Application number
AP2005003317A
Other languages
English (en)
Other versions
AP2005003317A0 (en
Inventor
Praveen Sharma
Narinder Singh Sahni
Anders Lonneborg
Original Assignee
Diagenic As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagenic As filed Critical Diagenic As
Publication of AP2005003317A0 publication Critical patent/AP2005003317A0/xx
Application granted granted Critical
Publication of AP2333A publication Critical patent/AP2333A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/20—Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Theoretical Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AP2005003317A 2002-11-21 2003-11-21 Product and method. AP2333A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0227238.3A GB0227238D0 (en) 2002-11-21 2002-11-21 Product and method
PCT/GB2003/005102 WO2004046382A2 (en) 2002-11-21 2003-11-21 Product and method

Publications (2)

Publication Number Publication Date
AP2005003317A0 AP2005003317A0 (en) 2005-06-30
AP2333A true AP2333A (en) 2011-12-06

Family

ID=9948301

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2005003317A AP2333A (en) 2002-11-21 2003-11-21 Product and method.

Country Status (19)

Country Link
US (2) US20070134656A1 (pt)
EP (1) EP1565574B1 (pt)
CN (2) CN102191319A (pt)
AP (1) AP2333A (pt)
AT (1) ATE459726T1 (pt)
AU (1) AU2003286262C1 (pt)
CA (1) CA2506887A1 (pt)
CY (1) CY1110543T1 (pt)
DE (1) DE60331577D1 (pt)
DK (1) DK1565574T3 (pt)
ES (1) ES2342161T3 (pt)
GB (1) GB0227238D0 (pt)
HK (1) HK1079554A1 (pt)
NO (1) NO20052544L (pt)
NZ (1) NZ540750A (pt)
PT (1) PT1565574E (pt)
SI (1) SI1565574T1 (pt)
WO (1) WO2004046382A2 (pt)
ZA (1) ZA200503797B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0412301D0 (en) * 2004-06-02 2004-07-07 Diagenic As Product and method
GB0422211D0 (en) * 2004-10-06 2004-11-03 Randox Lab Ltd Method
FR2900936B1 (fr) * 2006-05-15 2013-01-04 Exonhit Therapeutics Sa Procede et methodes de detection de la maladie d'alzheimer
US9995766B2 (en) * 2009-06-16 2018-06-12 The Regents Of The University Of California Methods and systems for measuring a property of a macromolecule
GB201000688D0 (en) 2010-01-15 2010-03-03 Diagenic Asa Product and method
WO2013064702A2 (en) * 2011-11-03 2013-05-10 Diagenic Asa Probes for diagnosis and monitoring of neurodegenerative disease
US10339527B1 (en) 2014-10-31 2019-07-02 Experian Information Solutions, Inc. System and architecture for electronic fraud detection
US10140708B2 (en) * 2016-01-21 2018-11-27 Riverside Research Institute Method for gestational age estimation and embryonic mutant detection
CN110669830B (zh) * 2019-10-24 2023-05-23 裕策医疗器械江苏有限公司 一种低质量ffpe dna的处理方法、装置和存储介质

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002059271A2 (en) * 2001-01-25 2002-08-01 Gene Logic, Inc. Gene expression profiles in breast tissue

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981783A (en) * 1986-04-16 1991-01-01 Montefiore Medical Center Method for detecting pathological conditions
US5871928A (en) * 1989-06-07 1999-02-16 Fodor; Stephen P. A. Methods for nucleic acid analysis
US6040138A (en) * 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5925525A (en) * 1989-06-07 1999-07-20 Affymetrix, Inc. Method of identifying nucleotide differences
US5800992A (en) * 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5633137A (en) * 1992-12-01 1997-05-27 The University Of South Florida Method for measuring specific gene expression: transcriptional activity per gene dose
US5677125A (en) * 1994-01-14 1997-10-14 Vanderbilt University Method of detection and diagnosis of pre-invasive cancer
US5830645A (en) * 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5545531A (en) * 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
US6190857B1 (en) * 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
NO972006D0 (no) * 1997-04-30 1997-04-30 Forskningsparken I Aas As Ny metode for diagnose av sykdommer
US5994076A (en) * 1997-05-21 1999-11-30 Clontech Laboratories, Inc. Methods of assaying differential expression
US6607879B1 (en) * 1998-02-09 2003-08-19 Incyte Corporation Compositions for the detection of blood cell and immunological response gene expression
US6004755A (en) * 1998-04-07 1999-12-21 Incyte Pharmaceuticals, Inc. Quantitative microarray hybridizaton assays
US20040265868A1 (en) * 1999-01-06 2004-12-30 Chondrogene Limited Method for the detection of depression related gene transcripts in blood
US20040241726A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of allergies related gene transcripts in blood
US20040241727A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of schizophrenia related gene transcripts in blood
US20040248170A1 (en) * 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of hyperlipidemia related gene transcripts in blood
AU1853600A (en) * 1999-01-06 2000-07-24 Choong-Chin Liew Method for the detection of gene transcripts in blood and uses thereof
US20050003394A1 (en) * 1999-01-06 2005-01-06 Chondrogene Limited Method for the detection of rheumatoid arthritis related gene transcripts in blood
US20050042630A1 (en) * 1999-01-06 2005-02-24 Chondrogene Limited Method for the detection of asthma related gene transcripts in blood
US20040265869A1 (en) * 1999-01-06 2004-12-30 Chondrogene Limited Method for the detection of type II diabetes related gene transcripts in blood
US20040241728A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of lung disease related gene transcripts in blood
US20040248169A1 (en) * 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of obesity related gene transcripts in blood
US7473528B2 (en) * 1999-01-06 2009-01-06 Genenews Inc. Method for the detection of Chagas disease related gene transcripts in blood
US20020169560A1 (en) * 2001-05-12 2002-11-14 X-Mine Analysis mechanism for genetic data

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002059271A2 (en) * 2001-01-25 2002-08-01 Gene Logic, Inc. Gene expression profiles in breast tissue

Also Published As

Publication number Publication date
AU2003286262B2 (en) 2008-02-21
NZ540750A (en) 2008-07-31
NO20052544L (no) 2005-06-20
WO2004046382A3 (en) 2004-07-22
ES2342161T3 (es) 2010-07-02
ZA200503797B (en) 2006-11-29
CA2506887A1 (en) 2004-06-03
ATE459726T1 (de) 2010-03-15
CN102191319A (zh) 2011-09-21
GB0227238D0 (en) 2002-12-31
HK1079554A1 (en) 2006-04-07
AP2005003317A0 (en) 2005-06-30
SI1565574T1 (sl) 2010-07-30
CY1110543T1 (el) 2015-04-29
PT1565574E (pt) 2010-06-07
EP1565574A2 (en) 2005-08-24
DE60331577D1 (de) 2010-04-15
CN1742101A (zh) 2006-03-01
DK1565574T3 (da) 2010-06-21
WO2004046382A2 (en) 2004-06-03
US20070134656A1 (en) 2007-06-14
AU2003286262C1 (en) 2008-09-18
AU2003286262A1 (en) 2004-06-15
US20130143761A1 (en) 2013-06-06
EP1565574B1 (en) 2010-03-03

Similar Documents

Publication Publication Date Title
GB0303730D0 (en) Process and product
ZA200309762B (en) Rock-bolting apparatus and method.
AU2003222408A1 (en) Garment and method for producing the same
EG25097A (en) Piprazinyl and diazapanyl benzamides and benzthioamides.
EP1467916A4 (en) CONTAINER AND ASSOCIATED METHODS
HK1079554A1 (en) Product and method
MXPA03008771A (es) Masa, productos y metodos.
MXPA03008693A (es) Aparato para pelar y metodos asociados.
MXPA02011986A (es) Sistema y metodo para produccion de documentos a la medida..
GB2390439B (en) Dataconferencing system and method
SG116514A1 (en) Liquid-ejecting method and liquid-ejecting apparatus.
AU2002257312A8 (en) Offer system and method
ZA200305081B (en) Rotary apparatus and method.
AU2003227195A1 (en) Method and device for shaping foodstuffs and the like, and shaped product
PL1633816T3 (pl) Produkt drzewny i sposób jego wytwarzania
GB0208999D0 (en) Process, equipment and products
AU2003301457A8 (en) Bioweapon-detecting fibrous-network products and methods for making same
GB0320304D0 (en) Product and process
HK1065900A1 (en) Tf-determination device, and tf-determination method
AU2003258776A8 (en) Methods for obtaining oligomannuronates et guluronates, products obtained and use thereof
GB0210289D0 (en) Product
GB0312747D0 (en) Products and methods
GB0203907D0 (en) Product
GB0321603D0 (en) Product and method
ZA200307890B (en) Advertising method and means.